Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV-16/ 18”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03206255
What this trial is testing

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 940
Large-scale testing (Phase 3)Study completedNCT00423046
What this trial is testing

Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 1,106
Not applicableStudy completedNCT03438006
What this trial is testing

A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects

Who this might be right for
Cervical Intraepithelial Neoplasia
GlaxoSmithKline 3,016
Not applicableUnknownNCT05045755
What this trial is testing

The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Jun Zhang 1,339
Not applicableStudy completedNCT03671369
What this trial is testing

A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Papillomavirus [HPV] -16/18 Vaccine), When Administered According to the Approved Prescribing Information (PI) in Korea

Who this might be right for
Neoplasms, Rectal
GlaxoSmithKline 670
Testing effectiveness (Phase 2)Looking for participantsNCT07175662
What this trial is testing

Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL

Who this might be right for
High-grade Squamous Intraepithelial Lesion (HSIL)
Newish Biotech (Wuxi) Co., Ltd. 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07702656
What this trial is testing

A Phase II Clinical Trial Evaluating the Efficacy and Safety of SYS6026 Injection in Participants With HPV16 or 18-related High-grade Cervical Squamous Intraepithelial Lesions

Who this might be right for
High-grade Cervical Intraepithelial Lesions
CSPC Megalith Biopharmaceutical Co.,Ltd. 175
Large-scale testing (Phase 3)Study completedNCT01735006
What this trial is testing

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Xiamen University 7,372
Not applicableUnknownNCT02411019
What this trial is testing

Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Genexine, Inc. 67
Not applicableStudy completedNCT01101542
What this trial is testing

Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 3,091
Testing effectiveness (Phase 2)Study completedNCT00263744
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of MEDI-517P in Healthy Adult Female Volunteers Who Are HPV-16 or HPV-18 DNA Positive

Who this might be right for
Healthy
MedImmune LLC 60
Large-scale testing (Phase 3)Study completedNCT01462357
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,079
Not applicableActive Not RecruitingNCT03309033
What this trial is testing

Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study

Who this might be right for
Human Papillomavirus InfectionHuman Papillomavirus-Related Malignant Neoplasm
National Cancer Institute (NCI) 946
Not applicableStudy completedNCT04000503
What this trial is testing

Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge)

Who this might be right for
Human Papillomavirus 16Human Papillomavirus 18Papillomavirus Infections+2 more
University of British Columbia 2,019
Not applicableActive Not RecruitingNCT06243666
What this trial is testing

Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerPersistent Infection
Xiamen University 2,188
Large-scale testing (Phase 3)Study completedNCT00196937
What this trial is testing

Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 667
Large-scale testing (Phase 3)Study completedNCT00169494
What this trial is testing

Human Papilloma Virus Vaccine Consistency and Non-inferiority Trial in Young Adult Women With GSK Bio HPV-16/18

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 770
Not applicableStudy completedNCT04369339
What this trial is testing

Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology

Who this might be right for
Human Papillomavirus Infection
Bezmialem Vakif University 185
Early research (Phase 1)Ended earlyNCT02689726
What this trial is testing

Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL

Who this might be right for
HPV 16- and/or HPV 18-Infected Women With Normal Cytology, ASCUS, or LSIL
Genticel 13
Large-scale testing (Phase 3)Study completedNCT00122681
What this trial is testing

Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 18,729
Next Page